DCT

1:22-cv-00431

Dana Farber Cancer Institute Inc v. Intas Biopharmaceuticals

General
Filed
06/07/22
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
SourcePACER
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
06/08/22 - 06/23/22
85%
Defendant
Attorney
No Attorneys